 | Up a level |
Auge, J., Vent, J., Agache, I., Airaksinen, L., Campo Mozo, P., Chaker, A., Cingi, C., Durham, S., Fokkens, W., Gevaert, P., Giotakis, A., Hellings, P., Herknerova, M., Hox, V., Klimek, L., La Melia, C., Mullol, J., Muluk, N. B., Muraro, A., Naito, K., Pfaar, O., Riechelmann, H., Rondon, C., Rudenko, M., Samolinski, B., Tasca, I., Tomazic, P., Vogt, K., Wagenmann, M., Yeryomenko, G., Zhang, L. and Moesges, R. (2018). EAACI Position paper on the standardization of nasal allergen challenges. Allergy, 73 (8). S. 1597 - 1609. HOBOKEN: WILEY. ISSN 1398-9995
Moesges, R., Demoly, P., Lehmacher, W., Durham, S., Shamji, M., Pirotton, S., Haazen, L. and Calderon, M. (2018). Safety of a 3-week allergen immunotherapy course with grass pollen peptides: A randomised double-blind placebo-controlled trial. Allergy, 73. S. 471 - 472. HOBOKEN: WILEY. ISSN 1398-9995